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Abstract.  
In this work, the capability of primary, monocyte-derived dendritic cells (DCs) to uptake iron 
oxide magnetic nanoparticles (MNPs) is assessed and a strategy to induce selective cell death in these 
MNP-loaded DCs using external alternating magnetic fields (AMFs) is reported. No significant 
decrease in the cell viability of MNP-loaded DCs, compared to the control samples, was observed after 
five days of culture. The amount of MNPs incorporated into the cytoplasm was measured by 
magnetometry, which confirmed that 1 to 5 pg of the particles were uploaded per cell. The intracellular 
distribution of these MNPs, assessed by transmission electron microscopy, was found to be primarily 
inside the endosomic structures. These cells were then subjected to an AMF for 30 min, and the 
viability of the blank DCs (i.e., without MNPs), which were used as control samples, remained 
essentially unaffected. However, a remarkable decrease of viability from approximately 90% to 2-5% of 
DCs previously loaded with MNPs was observed after the same 30 min exposure to an AMF. The same 
results were obtained using MNPs having either positive (NH2+) or negative (COOH-) surface functional 
groups. In spite of the massive cell death induced by application of AMF to MNP-loaded DCs, the 
amount of incorporated magnetic particles did not raise the temperature of the cell culture. Clear 
morphological changes at the cell structure after magnetic field application were observed using 
scanning electron microscopy. Therefore, local damage produced by the MNPs could be the main 
mechanism for the selective cell death of MNP-loaded DCs under an AMF. Based on the ability of 
these cells to evade the reticuloendothelial system, these complexes combined with an AMF should be 
considered as a potentially powerful tool for tumour therapy. 
  
Abbreviations: alternating magnetic field (AMF); dendritic cells (DCs); magnetic nanoparticles 
(MNPs). 
Keywords: Dendritic cells, magnetic nanoparticles, magnetic hyperthermia; cell 
viability, power absorption. 
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1. Introduction 
 
The increasing synergy between biomedicine and nanoscience has been applied 
to the use of magnetic nanoparticles (MNPs) in routine laboratory and clinical 
protocols, such as cell sorting, DNA separation, magnetic resonance imaging (MRI) 
and gene therapy.[1, 2] Applications of MNPs currently in preclinical stages include 
the cell-targeted delivery of anticancer agents and molecular diagnosis. [3, 4] 
Recently, magnetic hyperthermia strategies passed preclinical trial stages and received 
regulatory approval as a clinical protocol for thermotherapy.[5] Thus, with proper 
control of size and surface functionalisation, magnetic nanoparticles could become 
multifunctional intracellular agents for MRI, drug carriers and/or heat generators for 
hyperthermia. [6]  
Loading MNPs with anticancer drugs and targeting to specific tumour sites is a 
promising strategy for the detection and elimination of neoplastic tissue, even at the 
single-cell level. However, a major obstacle for this approach is that the 
reticuloendothelial system (RES) detects and phagocytoses MNPs, preventing their 
targeting and therapeutic action.[7] Attempts to overcome this difficulty (i.e., to evade 
the RES) have been made through the functionalisation of MNPs to mimic biologic 
entities already present in the blood system, resulting in the generation of ‘stealth’ 
carriers.[8]  
Eukaryotic cells can easily be ‘targeted’ in vitro with MNPs of different sizes. 
Different mechanisms have been reported for the detection and/or uptake of inorganic 
nanoparticles by cells, depending on the type of core material and surface coating of 
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the particles used. The general consensus is that the mechanisms involved in particle 
incorporation are strongly dependent on the cell type.[9] 
Dendritic cells (DCs) are the most important antigen-presenting cells, as they 
have a key role in the first steps of most immune responses. [10] Therefore, DCs are 
good candidates as therapeutic tools for immune diseases and malignant neoplasms. 
DCs are derived from bone marrow precursors and migrate to non-lymphoid tissues 
where they differentiate into dendritic cells.[11] As antigen-presenting cells, DCs are 
active at the membrane level and are thus good candidates to incorporate MNPs. 
Indeed, previously published reports have demonstrated that DCs can incorporate 
peptides, viral RNA,[12] bacterial DNA [13] and other molecules.[14] The uptake of 
antigens by DCs may occur by different processes, such as macropinocytosis, 
phagocytosis or receptor-mediated endocytosis [15]; more recently, the ability of DCs 
to incorporate several types of solid particles within a broad size range has also been 
described [16].  
In the present work, the first results for a new strategy are demonstrated, based 
on the use of dendritic cells as natural carriers of magnetic nanoparticles. This 
investigation had two major goals: a) to study the inclusion and toxicity of magnetic 
nanoparticles in dendritic cells and b) to induce cell death by applying a time-varying 
magnetic field to the MNP-loaded DCs. The reason for using DCs as carriers of MNPs 
was to mimic biological units and to elude the immune response of the body. The 
advantage of using this strategy is that the cargo of the DCs could be designed to be 
either ‘nude’ magnetic MNPs for hyperthermia therapy or functionalised MNPs with 
specific drugs that could be released by the application of alternating magnetic fields 
(AMFs). 
 5 
  
2. Materials and methods 
2.1. Magnetic nanoparticles 
A set of 18 different types of commercially available magnetic colloids 
(Micromod GmbH, Germany) [17] having different hydrodynamic sizes and surface 
functional groups was tested with respect to absorption efficiency (see Figure S1 of 
supporting information). All of the evaluated MNPs were composed of a magnetite 
core (Fe3O4) coated with a properly functionalised dextran shell at the surface. The 
average hydrodynamic size of these colloids spanned from 20 to 500 nm. The purpose 
of this serial evaluation of the specific power absorption (SPA) in different colloids 
was to identify samples with maximum heating efficiency because the final goal was 
to induce cell death by the application of an AMF. The two samples with the highest 
SPA values and similar hydrodynamic radii but opposite surface charges (the filled 
bars in Figure S1 of supporting material) were selected. The criterion for having two 
sets of MNPs, one positively (NH2+) and one negatively (COOH-) charged, was to 
avoid the possibility of decreasing the uptake affinity of the cells due to the surface 
charge of the MNPs. Samples with positively charged MNPs (positive because of 
amine groups at the surface, NH2+) and negatively charged MNPs (negative because of 
carboxyl groups at the surface, COOH-) were labelled as NH2(MNP)+ and 
COOH(MNP)-, respectively. In addition to the specifications from the provider [18], 
the nanoparticles were characterised through transmission electron microscopy (TEM), 
dynamic light scattering (DLS), and magnetisation measurements. 
The magnetic characterisation of colloids and cell cultures was performed in a 
commercial SQUID magnetometer (Quantum Design MPMS-XL) through static 
measurements as a function of field and temperature. Pure colloids were measured as 
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is (i.e., in the liquid phase) after being conditioned in sealed sample holders with 200-
µL capacity. Magnetisation data were collected in applied magnetic fields up to 5 T at 
temperatures between 5 K and 250 K to avoid the melting of the frozen liquid carrier. 
To determine the magnetic behaviour at room temperature, hysteresis loops M(H) 
were performed at T= 295 K in samples previously dried at room temperature. The 
same protocol was used for magnetic measurements in DC cultures. 
2.2. Dendritic cell differentiation from PBMCs 
Peripheral blood mononuclear cells (PBMCs) were isolated from normal blood 
by a density gradient (Ficoll Histopaque-1077, Sigma). Cells were washed twice with 
PBS and then centrifuged for 10 minutes at 800 rpm to avoid platelet contamination. 
The isolation of CD14+ cells was performed with magnetic beads (CD14 Microbeads, 
Miltenyi) by positive immunoselection using the autoMACS Separator (Miltenyi). 
CD14+ cells (106 cells/ml) were cultured in RPMI 1640 (Sigma) with 10% FBS, 1% 
glutamine, 1% antibiotics, IL-4 (25 ng/ml) and GM-CSF (25 ng/ml)(Bionova) for 5 
days at 37ºC. Every two days, the medium was replaced by fresh medium containing 
the same concentration of interleukins. The phenotype for the DCs was characterised 
by staining with fluorochrome-labelled antibodies against CD45, CD14 (BD 
Biosciences, San Jose, CA), CD11c (eBioscience, San Diego, CA), CD40, CD83 and 
CD86 (Invitrogen, Carlsbad, CA). The flow cytometry analysis was performed with 
the FACSCalibur cytometer and the data were analysed with FACSDiva software. 
2.3. Cytotoxicity assay 
On the fifth day of the differentiation process, loosely adherent and non-
adherent cells were collected, washed twice and seeded onto a 6-well plate at 106 
cells/ml (1 to 3x106 total cells per well). The cytotoxicities of COOH(MNP)- and 
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NH2(MNP)+ colloids were evaluated by adding 50 µg MNP/ml medium into three 
wells each; the cell viability was measured by Trypan blue, MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and flow cytometry using 
annexin-propidium iodide markers on days 1, 3 and 5 after the addition of the MNPs. 
The Trypan blue assay was conducted by diluting 10 µl of cell samples into trypan 
blue (1:1). 
For the MTT cell viability assay, 5x104 DCs taken from each sample were 
incubated with 20 μL (5 mg/ml) MTT for two hours at 37ºC, and the resultant 
formazan crystals were dissolved in 200 μL dimethyl sulfoxide. To avoid possible 
interference from remaining nanoparticles and/or cellular debris, all samples were 
previously spun down. The absorbance was measured by an microplate reader 
(ELISA) at 550 nm by placing 100 μl of each sample in a 96-well plate. The percent 
cell viability was calculated as: (absorbance treated cells/absorbance untreated cells) 
x100. Each assay was repeated three times.  
DC viability was further checked by flow cytometry using a commercial kit 
(Immunostep, Spain). DCs (106) of each sample were resuspended in Annexin-binding 
buffer and stained with 5 µl of Annexin and 5 µl of propidium iodide. DCs were 
incubated for 15 minutes in the dark at room temperature. Analysis of the results was 
performed using a FACSAria Cytometer and FACSDiva Software. 
2.4. Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) images were taken on an 80 kV 
TEM JEOL 1010. Samples were prepared by harvesting DCs on day 5 of 
differentiation, seeding them at 3x106 cells/well and incubating them with MNPs at a 
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concentration or 50 µg MNP/ml medium. DCs without MNPs were used as negative 
controls. Fixation of the cells was performed using 4% glutaraldehyde in 0.1 M 
sodium cacodylate for 2 hours at 4ºC; the cells were then washed three times with PBS 
and subsequently fixed for 1 hour using potassium ferrocyanide (2.5%) in 0.1 M 
sodium cacodylate and 2% OsO4. Finally, the cells were washed and dehydrated with 
acetone. The encapsulation was performed in EPON resin, and ultrathin sections (60-
80 nm) were cut by ultramicrotomy; the sections were then mounted on a 400-mesh 
nickel grid. The deposited slides were further dried and treated with 2% uranyl acetate.  
2.5. Specific power absorption experiments 
The specific power absorption (SPA) of the pure colloids was measured with a 
commercial ac field applicator (model DM100 from nB nanoscale Biomagnetics, 
Spain) at f = 260 kHz and field amplitudes from 0 to 16 mT; the applicator was 
equipped with an adiabatic sample space (~ 0.5 ml) for measurements in the liquid 
phase. For in vitro magnetic hyperthermia experiments, DCs cultured as described 
above were collected and seeded onto a 6-well plate at 106 cells/ml. COOH(MNP)- 
and NH2(MNP)+ nanoparticle suspensions (1% wt) were each added into two wells at 
a concentration of 50 µg MNP/ml medium. Two wells, each containing 106 cells/ml 
without nanoparticles, were used as a control. Cells were cultured overnight at 37ºC. 
The next day, cells were collected from each well and washed four times with fresh 
medium to remove the MNPs that were not incorporated. Cells were counted and 
resuspended in 500 μl of the medium.  
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Figure 1: Schematic representation of the ‘2x2’ experiment: (a) DCs with neither 
MNP uptake nor magnetic field application. (b) DCs uploaded with MNPs but without 
field application, (c) DCs without MNPs for magnetic field application, and (d) DCs 
with MNPs and the application of magnetic fields.  
 
 Each experiment consisted of four samples of cultured DCs, as illustrated in 
Figure 1. In this type of ‘2x2 experiment’, the first pair of samples, which consisted of 
as-cultured blank DCs (i.e., without nanoparticles, Fig. 2a) and MNP-loaded DCs 
(Fig. 2b), were not exposed to magnetic fields and analysed at the end of the 
experiment to compare the natural viability of the cell culture. The second pair of 
samples, both blank and MNP-loaded DCs (Figures 2c and 2d), were exposed to the 
AMF (f= 260 kHz, H= 16 mT) for 30 minutes and, simultaneously, the temperature of 
the medium was measured as described elsewhere. [19] After the field exposure, cell 
viability was measured in the four samples using Trypan blue and FACS (annexin-
propidium iodide) protocols, as previously described. 
2.6. Morphological analysis by scanning electron microscopy (SEM) 
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We investigated the possible effects of the alternating magnetic fields on cell 
morphology using scanning electron microscopy (SEM). Images taken of MNP-loaded 
cells with and without hyperthermia were obtained with a FEI INSPECT F 
microscope. The samples were prepared by fixing the cells with 2.5% glutaraldehyde 
in 0.1 M sodium cacodylate and a 3% sucrose solution for 90 min at 37ºC. The 
dehydration process was conducted by incubating the cells for 5 min with increasing 
concentrations of methanol and anhydride methanol for 10 minutes. All samples were 
sputter-coated with gold immediately before observation.  
3. Results and discussion 
3.1. Magnetic nanoparticles 
Figure 2 shows a typical TEM image of the colloids used in this work. As a general 
feature, the magnetic cores possessed cubic-rounded morphology, with some degree of 
agglomeration, even after strong ultrasonication and extensive dilution. Therefore, the 
presence of agglomerates in the colloidal suspensions could not be eliminated. The 
average sizes of the magnetic cores were obtained after counting over 100 nuclei from 
different images and fitting the resulted histogram with a log-normal function. This 
shape was chosen after finding a notable fraction of large, cubic-shaped particles in 
both samples. The resulting diameters were <d> = 13±2 and 15±2 nm, and the 
dispersion values were σ = 0.5 and 0.6 for samples NH2(MNP)+ and COOH(MNP)-, 
respectively.  
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Figure 2: TEM image of Fe3O4 nanoparticles with magnetic cores of 
<d> = 13(2) nm, functionalised with NH2+ groups at the surface.  
 
 The hydrodynamic diameters of the colloidal nanoparticles were extracted 
from the DLS curves at room temperature. Both NH2(MNP)+ and COOH(MNP)- 
samples displayed a log-normal profile (Figure 3), with a broad peak at approximately 
240 nm and a ‘tail’ from the contribution of larger particle sizes. The large value of dH 
(≈18 times the size of the magnetic core) exemplified the importance of the organic 
coating for biomedical applications because the particle aggregates that were close to 
the micrometer range would have likely been difficult to incorporate by the usual 
endocytosis mechanisms. Because DLS measurements were performed on highly 
diluted colloids, the observed dispersion of the particle sizes (σH = 0.40-0.50 values of 
the fitting log-normal function) reflected the presence of clustered units in the colloid, 
which was in agreement with the agglomeration observed in the TEM images 
discussed above.  
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Figure 3. DLS results for the NH2(MNP)+ (solid line) and COOH(MNP)- (dashed 
line) nanoparticles.  
  
 The SPA values for the different types of commercial MNPs tested varied from 
18 to 36.6 W/g (Figure S1 in the supporting material). The SPA is known to depend 
strongly on the average particle size, size dispersion, particle interactions (through 
magnetic dipolar interactions) and the hydrodynamic diameter. [20, 21] There is 
usually a narrow size window where the SPA is maximised; this window is centred at 
some value that depends on magnetic parameters such as saturation magnetisation and 
magnetic anisotropy of the core material. Because the purpose of this study was to 
induce cell death with a minimum amount of MNPs, the two samples having a) the 
highest SPA values and b) opposite surface charge were selected for investigation of 
the optimal cellular uptake. The pair of samples with the highest SPA values and 
opposite surface charges corresponded to samples NH2(MNP)+ (SPA=36.8 W/g) and 
COOH(MNP)- (SPA=46 W/g). 
Figure 4 shows the magnetisation data M(T) as a function of the temperature of 
both NH2(MNP)+ and COOH(MNP)- samples, obtained in zero-field cooling (ZFC) 
and field-cooling (FC) modes. The similar behaviours reflect the similar size and 
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composition of the magnetic cores of both samples. The continuous increase of the 
M(T) data taken in ZFC mode (Figure 4) suggest that the blocking temperature, TB, 
was close to the maximum measured temperature. The single-domain nature of the 
particles was inferred from the absence of the jump in M(T) curves in the ZFC mode, 
which is expected for the Verwey transition in multidomain particles.[22-24] In 
agreement with the proximity of the TB inferred from the M(T) data, the hysteresis 
loops M(H) performed at 295 K in the lyophilised colloids showed nearly a zero 
coercive field HC (see Figure 4), which indicates the presence of single-domain 
nanoparticles in the superparamagnetic regime. The magnetic parameters extracted 
from the M(H) curves at low temperatures (Figure S2 of the supporting information) 
indicated a slightly reduced MS, which is frequently found in Fe3O4 particles with 
average size <d>≈10 nm and attributed to surface spin disorder. [22] The relevant 
magnetic parameters are summarised in Table I.  
Table I: Chemical and physical parameters of the nanoparticles used in this work: surface 
functional groups, core size dCORE, hydrodynamic size (dH), distribution (σH), saturation 
magnetisation (MS), coercive field (HC) at room temperature, and specific power absorption 
(SPA) values.  
Sample Core material 
Surface 
charge 
dCORE dH σH MS HC SPA 
(nm) (nm)  (emu/g) (Oe) (W/g) 
NH2(MNP)+ Fe3O4 NH2
+ 13(2) 244(2) 0.48 62.3 12(5) 36(6) 
COOH(MNP)- Fe3O4 COOH- 15(2) 217(2) 0.43 68.0 12(5) 46(6) 
 
In summary, the magnetic characterisation of both colloids used in this work 
indicated a single-domain structure of the MNP core with superparamagnetic 
behaviour in agreement with previous results for Fe3O4 nanoparticles at similar 
sizes.[22, 24]  
 14 
-40 -20 0 20 40
-60
-40
-20
0
20
40
60
-400-200 0 200 400
-20
0
20
0 50 100 150 200 250
3
6
9
12
b
 
 
M
(e
m
u/
gF
e 3
O
4)
H(kOe)
 MCM+
 MCM-
a
M
(e
m
u/
gF
e 3
O
4)
 
 
H(Oe)
M
(em
u/gFe
3 O
4 )
 
 
T(K)
 ZFC MCM+
 FC MCM+
 ZFC MCM-
 FC MCM-
T = 295 K
 
Figure 4: Magnetic data from magnetic colloids used in this work. a) Hysteresis loops 
M(H) at room temperature. The inset shows the small coercive field; b)ZFC-FC data for 
the same colloids, showing the single-domain behaviour with blocking temperatures 
above 250 K. 
 
3.2. Dendritic cell differentiation from PBMCs 
Monocytes (CD14+) cultured for 5 days in the presence of GM-CSF and IL-4 
showed the characteristic phenotype of immature DCs. As shown in Figure 5, the 
expression of the main markers characterising immature DCs was confirmed: CD45 (a 
leukocyte common antigen); CD40 (a common feature of TNF receptor family 
members, which play an important role in the maturation of DCs) and CD11c (a 
transmembrane protein present at high levels on most human DCs). Additionally, the 
absence of specific markers, such as CD14 (expressed by monocytes but not expressed 
by DCs), CD83 and CD86 (typically absent for immature DCs but present after 
maturation), was observed. The combination of the above results (both positive and 
negative) confirmed that the phenotype of the cultured cells corresponded to immature 
DCs. This result was a requisite for the vectorization of MNPs to neoplastic tissue 
because the overall strategy relies on the ability of immature DCs to transdifferentiate 
into endothelial cells when cultured in the presence of angiogenic growth factors [25] 
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or tumour-conditioned media.[26] When DCs are stimulated by antigens and 
consequently reach a mature state, they lose their multipotency to differentiate into 
other types of cell.[27, 28] Therefore, giving the immature phenotype sufficient time 
for the DCs to reach the desired organ is essential for any potential therapeutic 
application. 
 
Figure 5: Surface antigen expression measured by FACS for 5-day-cultured 
cells. The labels in each figure denote the type of FITC or PE-conjugated 
antibodies used in each case. The resulting phenotypes were immature DCs. 
 
3.3. Viability of DCs cultured with MNPs 
The cytotoxicity produced by MNPs was another obstacle that needed to be 
overcome for biomedical applications. Therefore, the first step to evaluate the actual 
potential of this strategy was to determine whether DCs could incorporate this type of 
MNPs without affecting the viability of the cells. In a previous work, Wang et al. [29] 
studied the uptake of multiwalled carbon nanotubes (CNT) by immature dendritic cells 
(iDCs) and found that the incorporation of CNTs did not induce phenotypical changes 
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in iDCs and did not affect the normal activation by lipopolysaccharides. Polystyrene 
particles have also been widely used for this purpose because they are commercially 
available with different fluorescent markers, surface charges and well-defined sizes 
(from a few nanometres to a few microns). [30] The use of these types of particles has 
demonstrated that the cytotoxic effects depend on both the size and surface charge.[30, 
31] The potential of biodegradable nanoparticles for antigen delivery using DCs has 
been demonstrated in vivo by Matsuo et al. [32], who reported the inhibition of tumour 
growth in C57BL/6 mouse experiments. 
 
Figure 6: Trypan blue results of cell viability for several five-day experiments with DCs 
loaded with positively (NH2(MNP)+) and negatively (COOH(MNP)-) charged 
nanoparticles. The primary DC culture without MNPs showed a natural decrease of viability 
from approximately 95% to 64 % on the fifth day. The same trend, within experimental 
error, was displayed by DCs loaded with both types of MNPs. The data and error bars 
represent the mean and SD of n=3 independent experiments. 
 
The cytotoxicity of the MNPs used in this work was verified by Trypan blue, 
flow cytometry and MTT analyses. The obtained results are shown in Figure 6, where 
the viability of DCs exhibited a decreasing trend from day 1 to 5 of co-culture for both 
NH2(MNP)+ and COOH(MNP)- in a manner similar to that of the control sample 
(without MNPs); the viability remained above 65-70% on the fifth day of culture. It is 
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worth mentioning that the DCs used in this work are primary cells; therefore, they 
have a finite life span in culture, as opposed to immortalised cell lines. Flow cytometry 
and MTT assays (Figures S3 and S4 in the supporting material) confirmed that the 
decrease of cell viability after five days was not affected by the incorporation of 
MNPs. 
3.4. TEM study of internalisation  
Optimisation of the uptake of MNPs by the DCs was required before these 
cells could be used as carriers to the tumoural vasculature.[33] This, in turn, required 
the determination of the uptake mechanisms involved for a given type of particle and 
cell line because these mechanisms would determine the uptake kinetics and 
intracellular fate of the nanoparticles. Endocytosis has been recognised as the most 
common passive mechanism for the MNP uptake by different cellular types, including 
HeLa cells, fibroblasts and DCs. The intracellular localisation of the MNPs was 
evaluated by TEM images of DCs cultured with MNPs during a 24-h period. In Figure 
7, a series of representative TEM images illustrated that the uptake sequence in DCs 
was a stepwise process in which the MNPs were first attached to the cell surface and 
subsequently internalised by vesicle-mediated endocytosis. After attaching to the 
external side of the cell (Figure 7a), the invagination of the cell membrane began at 
the areas of contact (the arrow in Figure 7b) to form an endosomal structure that 
finally progressed to the cell interior with most of its volume occupied by the 
endocytosed MNPs (Figure 7c-d). Although the different stages of the uptake process 
were present in all samples observed, the fraction of mature endosomes was 
predominant. 
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The above results were in agreement with previously reported data [34] 
showing that monocyte-derived DCs were able to incorporate Fe@C magnetic 
nanoparticles and that the intracellular distribution of these MNPs was primarily 
located in the cytoplasmatic compartments.  
 
Figure 7: TEM images of DCs incorporating COOH(MNP)- nanoparticles. The sequence of the four 
panels represents a possible path for MNP incorporation: (a) the arrow indicates the presence of 
MNPs bound to the cell surface. The invagination of the cell membrane can be clearly seen in (b), 
capturing the attached MNPs. The lower panels (c) and (d) show the completed endosome with large 
amounts of MNPs inside.  
 
Several studies have also reported the uptake of different complexes, such as 
latex-type nanospheres, by DCs [35, 36] and the capacity of DCs to incorporate a wide 
range of antigens and molecules [37, 38]. In many cell lines, the uptake of MNPs 
occurs in a concentration- and time-dependent manner[39] that depends on some 
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specific features of the MNPs involved. In the absence of surface functionalisation of 
MNPs with specific biologic ligands, as in the case of the present MNPs, the most 
probable mechanism involved in MNP uptake is nonspecific endocytosis. 
3.5. Quantification of uploaded MNPs 
Magnetic measurements of the MNP-loaded DCs were performed as a simple 
way of quantifying the amounts of magnetic material incorporated. Figure 8 shows the 
low-temperature M(H) hysteresis loops for DCs cultured with COOH(MNP)- and 
NH2(MNP)+ particles at the same concentration of 50 µg MNP/ml medium. All data 
refer to 106 cells and a control sample (i.e., 1x106 DCs without MNPs), which was 
measured at the same temperature to subtract the diamagnetic signal from the DCs at 
low temperatures (see the lower inset in Figure 8). The similar saturation 
magnetisation extracted from both M(H) curves revealed that the incorporation of 
MNPs did not depend on the surface charge (Figure 8). Similar experiments performed 
on DCs cultured with increasing concentrations (50, 150 and 300 µg MNPs/ml 
medium) demonstrated that the MNPs were incorporated into DCs in a concentration-
dependent manner (see Figure S5 in supporting material). A non-linear increase of the 
magnetic signal was observed for higher concentrations of MNPs added, which was 
likely due to excess MNPs remaining in the culture medium after washing of the 
cultures. At a high MNP concentration, a brownish colour was observed for the cell 
medium, which indicated that excess magnetic nanoparticles mixed with the medium 
and could not be totally removed; this influenced the total magnetic signal.  
Using the MS values for the pure ferrofluid and the average volume of the 
magnetic cores extracted from TEM images, the average number of MNPs per cell 
was determined to be 1x104 to 7x104 MNPs/cell. This relatively small number of 
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particles was able to induce cellular death when submitted to an AMF, as will be 
discussed in the next sections.  
 
Figure 8: Main panel: low-temperature magnetic signal from 1x106 DCs cultured with COOH(MNP)- 
(squares) and NH2(MNP)+ (circles) at a concentration of 50 µg MNPs/ml medium. The diamagnetic 
signal of 1x106 blank DCs (lower inset) was subtracted in all cases. Upper inset: normalised initial 
magnetisation M(H)/MS curves at T = 250 K. The scaling of pure ferrofluid (open circles) and both 
types of MNPs inside the DCs (triangles and crosses) reflects the non-interacting behaviour of the 
MNPs. The solid line is the corresponding Langevin fit using equation (1). 
 
 To study the physical state of aggregation of the MNPs in the intracellular 
space, the magnetic state of the MNPs at room temperature was analysed in samples of 
DCs+MNPs that were previously lyophilised. Similar to the pure colloids at room 
temperature (Figure 4), the particles uploaded by the cells displayed SPM behaviour 
reflected in the M(H) curves with null coercivity at 250 K (upper inset of Figure 8). 
The magnetisation of such particles in the SPM state is described by the expression 
M=MS L(x), where MS is the saturation magnetisation and L(x) is the Langevin 
function with x=µH/kBT, µ is the magnetic moment of a single MNP, H is the applied 
field, kB is the Boltzmann constant and T is the temperature. To take the volume 
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distribution into account, the SPM magnetisation of the particles was better described 
as a weighted sum of Langevin functions [22]. 
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where f(V) represents the distribution function of the particle volume, which is 
usually assumed as a log-normal function. It should be noted here that this expression 
assumes that the system is composed of noninteracting particles. The fit of the M(H) 
curves at room temperature using Eq. (1) for a) as-prepared ferrofluid and b) 
magnetically loaded DCs resulted in identical fitted parameters within error, as shown 
by the scaling of the corresponding M(H) curves in the upper inset of Figure 8. This 
result indicates that a) the Fe3O4 phase was not reduced/oxidised in the intracellular 
medium and that b) the particle size distribution remained essentially unaltered after 
the incorporation into the DCs (i.e., no selective sizes were incorporated). As 
discussed previously, the TEM images showed that MNPs were agglomerated inside 
the endosomal spaces[34]; therefore, it was concluded that the dextran/functionalised 
shell was sufficiently thick to prevent strong interparticle interactions. This is an 
important issue for heating experiments in vitro because strongly interacting MNPs 
could result in a decrease of the power absorption. [40]  
3.6. Power absorption experiments 
Once the incorporation of MNPs was verified and the cytotoxicity was 
evaluated, the effects of AMF were studied in MNP-loaded DCs. The heating 
efficiency of the magnetic colloids was measured through the absorbed power P 
divided by the mass mNP of the constituent nanoparticles diluted in a mass mLIQ of the 
liquid carrier. The expression for the SPA can be written as follows [6]:  
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where cLIQ and cNP are the specific heat capacities of the liquid carrier. Because the 
concentrations of MNPs are usually in the range of 1 % wt., we can approximate [21] 
mLIQ cLIQ + mNP cNP ≈ mLIQ cLIQ and (2) can be written as follows: 
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where δLIQ and φ are the density of the liquid and the weight concentration of the 
MNPs in the colloid, respectively. The conversion from magnetic field energy into 
heat by the absorbing elements (i.e., the magnetic nanoparticles) at the frequencies of 
the experiment was due to the Néel relaxation process. Many recent reports have 
shown the details of this mechanism, which involves heat transference from 
nanoscopic agents (MNPs) to the macroscopic scale of the colloid. The common 
finding is that there is a strong dependence of SPA on particle size, with a narrow peak 
of absorption near the single- to multi-domain transition.[41, 42] As this represents a 
heat transference mechanism, an adiabatic experiment was needed to obtain actual 
SPA values for the given material by measuring the exact energy released as the 
temperature increased within the sample. Because the heating of a macroscopic 
amount of the sample took 102 to 103 seconds, high insulation was needed to provide 
adiabatic conditions during the whole experiment. Complete insulation is seldom 
attained in hyperthermia experiments [43], as can be inferred from the measurable 
decrease of the temperature when the field was turned off. This condition hindered the 
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accurate determination of the final temperature that could be attained with a given set 
of nanoparticles. However, the criterion for choosing a representative SPA value was 
related to the maximum slope of the T vs. time curves, which occurred during the first 
seconds of the experiments; thus, it can be ensured that the system behaved 
adiabatically because the amount of heat lost during this short interval could be 
neglected. Conversely, in vitro and in vivo power-absorption experiments were 
performed under strong heat-exchanging conditions, and therefore, it was neither 
possible nor interesting to quantify the power absorbed by the MNPs or the cells. 
Although the measured parameter in the hyperthermia experiments was the 
temperature increase of the cell culture, the resulting cellular damage had to be related 
to the actual intracellular temperatures attained. However, to the best of our 
knowledge, there are no detailed studies on the dynamics of heat conduction from the 
intracellular medium through the cell membrane.  
For each power absorption experiment, the DC cultures were always conducted 
in parallel wells (i.e., two wells each for blank and MNP-loaded DCs) to compare the 
viability between cells that were submitted to AMF and those that were not. The 
results of these experiments (Figure 9) indicated 70-95% viability in the blank samples 
and loaded DCs with no exposure to the magnetic field (figures 9a and 9b) and in the 
MNP-unloaded DCs subjected to AMF for 30 min (Figure 9c). Conversely, the 
application of the magnetic field to MNP-charged DCs resulted in a sharp decrease of 
cell viability to 2-5 % (Figure 9d), demonstrating the efficacy of an AMF for killing 
the targeted cells. Data from the Trypan blue viability analysis (not shown) confirmed 
these results regarding the viability of targeted DCs with and without the application 
of AMF. A complementary series of experiments conducted using DCs loaded with 
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NH2(MNP)+ nanoparticles (Figure S6 of the supporting information) showed the 
same effect of the AMF on MNP-loaded DCs. 
 
Figure 9: A typical experimental result for the ‘2x2’ experiments schematised in Figure 1. 
Viability from FACS data for: (a) non-loaded DCs with magnetic field OFF, (b) DCs with 
COOH(MNP)- particles with magnetic field OFF, (c)non-loaded DCs after application 
of 30 min of AMF and (d) DCs loaded with COOH(MNP)- particles after application of 
30 min of AMF. The green dots at quadrant Q3 indicate the viable cells in each 
experiment. Lower panel: Same data and error bars representing the mean and SD 
(n=3) of the ‘2x2’ experiments.  
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Interestingly, the temperature of the cell medium measured by the macroscopic 
optic sensor remained within 29-31 ºC (see Figure 10) (i.e., a few degrees above the 
starting temperature of 26 ºC) but well below the values of 43-46 ºC needed to trigger 
temperature-induced apoptosis by hyperthermia. The absence of a macroscopic 
temperature increase during the cell death observed for samples d) and f) raised the 
question of a possible intracellular mechanism that differed from the temperature 
increase of the intracellular medium.  
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Figure 10: Heating curves for pure colloids NH2(MNP)+ and COOH(MNP)-, 
during the application of alternating magnetic fields (H = 160 Oe, f = 260 kHz). 
The same experiment for DCs loaded with NH2(MNP)+ and COOH(MNP)- 
(bottom curves) produced a much smaller temperature increase to 29-32 ºC after 
30 min of exposure to the AMF. 
 
In a series of comprehensive experiments using CoFe2O4 and γ-Fe2O3 magnetic 
MNPs, Fortin et al. showed that heating can be achieved with a concentration of 25-30 
pg at the intracellular level.[44] This concentration was larger than that observed in the 
experiments herein, in which a maximum concentration of 5 pg MNP/cell was 
obtained after incubation in medium with 300 µg MNP/ml during a 12 h period (as 
shown in Figure S5 of the supporting material); the main reason for these differences 
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could be related to the different affinities for MNPs among different cell lines. As 
observed in Figure 10, the total amount of MNP taken up after co-culture was not 
sufficient to raise the temperature of the whole cell culture when submitted to an AMF 
in the thermally insulated system. This was consistent with the low average 
concentration of MNPs (2 µg MNPs/ml medium) in the experiments, as calculated 
from the 106 DCs containing an average of 1.07 pg MNPs each and dispersed in 0.5 ml 
of medium. If the calculation for the MNP concentration was restricted to the 
intracellular medium with the internalised MNP amount of 1.07 pg/cell and 
considering an average cell volume (from SEM images) of Vcell=500 µm3, then the 
resulting intracellular MNP concentration would be ≈2 mg/ml, which was not 
sufficient to raise the temperature of the intracellular medium with the present 
experimental conditions (H= 160 mT, f= 260 kHz). It was concluded that the 
temperature increase of the cell culture was not a relevant parameter for induction of 
cell death by an AMF in MNP-loaded DCs. 
Apoptosis or cellular programmed death is a particular mechanism in which a 
cell follows a programmed sequence of events to “prepare” for its death with minimal 
disturbance of the whole population. This phenomenon seems to be present in a wide 
range of organisms from primitive to higher eukaryotes. An early event that is 
considered a marker of this process is the exposition of phosphatidylserine on the 
external surface of the plasma membrane. The FACS results of Figure 9 indicate that 
incubation of DCs with annexin (which reveals the translocation of 
phosphatidylserine) and propidium iodide (which reveals damage in the plasma 
membrane) are both positive only for magnetically charged DCs after the application 
of the AMF (Figure 9d and Figure S6 d in the supporting material).  
 27 
It is important to stress that the experimental protocols were designed to 
perform the viability analysis immediately after exposure to the AMF. In spite of the 
short time elapsed between the AMF exposure and FACS measurement 
(approximately 2 hours), a clear shift of the cell populations along both axes (samples 
d and f) was observed, which was evidence of late apoptotic or necrotic cells.  
The SEM images obtained from the cell cultures (see Figure 11) showed a clear 
effect on the membrane integrity after AMF experiments in the DCs loaded with 
nanoparticles, whereas the cells without loaded MNPs retained the complex membrane 
structure of functional DCs. The short time elapsed and the large damage observed at 
the membrane level support the hypothesis of a necrosis-like process. The large 
channels observed in Figure 11(b) suggest that after exposure to the AMF, the cells 
lose all membrane activity and become permeable. The origin of such a dramatic 
effect attained by a relatively small amount of MNPs (≈1 pg MNPs/cell) is not yet 
clear, but the short time involved (30 min of AMF application and a one-hour interval 
before cells were fixed for SEM images) suggests that the process is of a physical 
nature as opposed to a programmed loss of metabolic activity followed by cell death. 
In addition, the release of the power absorbed by the MNPs did not yield a 
macroscopic temperature increase when the temperature was measured in the whole 
culture medium by a macroscopic probe. The possibility remains, however, that the 
temperature of the intracellular medium increased during the AMF application, 
resulting in metabolic and/or cytoskeleton damage. This hypothesis must be tested 
using a yet-undeveloped microscopic, intracellular temperature probe, and work along 
this direction is currently being performed.  
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Figure 11: SEM images of DCs after the application of the AMF for 30 min: a) and b) cells not 
loaded with COOH(MNP)-; c) and d) DCs loaded with MNPs. Note the evident loss of membrane 
structure and ‘shrinking’ of the cells in c) and d). Note also in c) the large channels opened in the 
membrane. 
 
In spite of the experimental difficulty for measuring intracellular temperatures, 
some theoretical calculations were performed to evaluate the capability of the number 
of MNPs incorporated to release sufficient energy to damage the subcellular structure. 
From the average particle diameter of the MNPs measured by the TEM images, the 
number of particles within a single cell was estimated to be ≈1x104. Assuming the 
same power absorption as the pure ferrofluid (36-46 W/g, see Table I), this amount of 
MNPs could release a total power of ≈2x10-10 W to the nearest organelles. If a short 
release time of 10 s was considered, the total energy available for local damage could 
be on the order of 1x1010 eV. Compared to typical binding energies per atom in 
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organic molecules (EC-N=308 eV, EC-C=348 eV, EC=C=614 eV), the previous estimation 
indicates that there should be sufficient energy available to induce bond breakage in 
the organic structures surrounding the MNPs.  
The confinement of these particles within endosomal structures (as observed 
from the TEM images) drastically reduced their contact with intracellular structures. 
Therefore, it seems plausible that the MNPs agglomerates observed inside the 
endosomes would be able to disrupt the endosomic membrane during AMF 
application. Endosomes and lysosomes are acidic vesicles involved in the endocytic 
pathway, and the lysosomes are the terminal degradation compartment of the 
phagocytosed material. Thus, the consequences of the local damage to the lysosomal 
membrane (i.e., the release of the lysosomal content into the cytoplasm) could induce 
changes in the intracellular medium that could lead to cell death. 
Although a complete analysis of the actual mechanism at the cellular level 
would require a study of a variety of markers, such as proteases, caspases, and 
cytokines, the large fraction of dead cells observed in such a short time suggests that a 
necrosis-like process was the main cause of cell death during magnetic field 
application. The precise nature of this mechanism is of crucial importance for future 
application protocols because necrosis must always be avoided in vivo due to the lethal 
consequences to the surrounding tissues. If the energy release is the cause of cellular 
damage, the application time and power could be regulated to a value at which only 
apoptosis is triggered. 
The combined results of a) low cytotoxicity of the magnetic MNPs and b) cell 
death after the application of an AMF suggest that MNP-loaded DCs could be used as 
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magnetic carriers to tumoural regions, where cellular death induced by an external 
magnetic field could be used as a therapy against tumour growth.  
 
4. Conclusions 
Based on the described ability of DCs to be loaded with magnetic 
nanoparticles, they appear to be a potentially powerful ‘Trojan horse’ system for MNP 
delivery to specifically targeted sites. The results indicate that the MNPs had 
negligible cytotoxic effects and that the functionality of the DCs was maintained, 
which supports the feasibility of this approach. Therefore, the demonstration of AMF-
induced cell death makes the selective killing of MNP-loaded cells feasible. The 
detailed intracellular mechanism has yet to be determined; however, preliminary 
results suggest an initial disruption of the endosome/lysosome membrane by the 
MNPs that resulted in the release of their content with subsequent cell death.  
In combination with magnetic nanoparticles and hyperthermia treatments, DCs 
may become a useful tool for many biomedical applications. The ability of DCs to 
transdifferentiate into endothelial-like cells under pro-angiogenic conditions and 
interact with the tumoural vasculature has been previously reported. [45] Therefore, 
DCs loaded with MNPs ex vivo could be vectorized or injected in situ at tumour sites 
to the pro-angiogenic microenvironment present in the tumour area. DCs might 
differentiate to endothelial-like cells and integrate into the new vasculature. Death of 
the MNP-loaded cells and, therefore, the tumour blood supply through the exposure to 
AMFs could prevent tumour vessel network formation and constitute a highly 
selective treatment for cancer patients. 
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